Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled crossover study of levodopa/carbidopa effects on finger tapping tasks in Parkinson's disease
2020-000686-16Phase 2Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoint: Tolerability and safety of levodopa/carbidopa and placebo. Started Mar 2020; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2020-000686-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000686-16.